L ymphopoiesis is a tightly controlled process depending on the interplay of defined transcriptional programs and environmental cues, such as cytokine signals. Lymphocytes arise from self-renewing hematopoietic stem cells (HSCs) via multiple intermediates including various subsets of multipotent progenitors (MPPs) and common lymphoid progenitors (CLPs). Although direct precursor-progeny relationships between these progenitor populations still remain elusive to some extent, there is substantial evidence that CLPs form the main source of B cell development in the bone marrow (BM) (1) . In contrast, T cell development can probably be sustained by multiple thymus-colonizing BM-derived progenitor populations with different degrees of lineage restriction including MPPs, CLPs, and potentially others (2) (3) (4) (5) . Inside the thymus T cell progenitors undergo a series of differentiation steps starting with the process of T lineage commitment, which is controlled by a network of transcription factors and sustained by cytokines such as IL-7 and stem cell factor (6) . Subsequently, the TCR repertoire is formed by TCR gene rearrangements coupled with selection events. Successful selection generally results in cell survival, further differentiation and proliferative expansion (7) .
IL-7 constitutes one of the major cytokines supporting lymphopoiesis (8) . Thus, T and B cell differentiation are severely impaired in mice and humans carrying defects in IL-7 signaling, such as Il7ra 2/2 , Il7 2/2 , or Il2rg 2/2 mice and X-SCID patients, respectively (9) (10) (11) . However, B and T cell development are differently affected by abolition of IL-7 signaling. In murine B lymphopoiesis, IL-7 mediates lineage commitment at the level of CLPs as well as cell survival at different developmental stages (9, 12, 13) . In contrast, the role of IL-7 during T cell development (with the exception of gdT cells) appears to be largely restricted to providing survival signals (14, 15) . Regulation by miRNAs has been proposed to constitute an additional layer of complexity in the process of lymphoid development (16) . B lineage-specific ablation of Dicer, a core component of the miRNA processing machinery, results in a developmental block at the pro-B to pre-B transition and a number of miRNAs, including miR-155, miR-150, miR-34, and miR-17∼92 have directly been implicated in controlling B cell development (17) (18) (19) (20) (21) (22) . Deletion of Dicer in double-negative (DN)3 thymocytes results in impaired abT lineage differentiation (23) . Furthermore, miR-181a has been reported to modulate thymic selection and promote B lineage differentiation at the expense of T lineage differentiation (24) (25) (26) .
miR-17∼92 constitutes a cluster of six miRNAs (miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1, and miR-92-1), which are processed from a single primary transcript. Deletion of miR-17∼92 in mice results in early postnatal fatality, largely because of defects in lung and heart development. Within the hematopoietic system, loss of miR-17∼92 results in a block in B cell development at the pro-B stage (22) . Overexpression of miR-17∼92 in lymphoid cells results in lymphoproliferation affecting both B cells and T ceIls (27) . Correspondingly, miR-17∼92 carries oncogenic potential and was therefore also termed oncomir-1 (28) . Individual members of the miR-17∼92 cluster, and miR-19 in particular, cooperate with c-Myc and Notch in promoting B cell malignancies and T cell acute lymphoblastic leukemia, respectively (29) (30) (31) . In the periphery, miR-17∼92 controls T cell proliferation and has been shown to modulate differentiation of follicular Th cells as well as regulatory T cells (32) (33) (34) . Despite its role in peripheral T cell differentiation and its contribution to T lineage leukemogenesis, the role of miR-17∼92 in physiological T cell development has not been addressed yet.
In this study, we analyzed mice deficient in miR-17∼92 in all hematopoietic cells. miR-17∼92-deficient cells displayed profound defects in T cell development. Phenotypic and functional analyses revealed reduced levels of surface expression of IL-7Ra (CD127) and, consistently, limited responsiveness of prethymic as well as intrathymic progenitors to IL-7. Thus, our study reveals a novel role for miR-17∼92 in T cell development and underscores its function as a general modulator of lymphopoiesis.
Materials and Methods

Mice Mirc1
tm1.1Tyj /J mice (termed miR-17∼92 fl/fl mice throughout this paper) and B6.Cg-Tg(Lck-cre) 548Jxm /J (Lck-Cre) were obtained from The Jackson Laboratory (Bar Harbor, ME) (22 fl/fl mice were bred at the animal facility of Hannover Medical School. Animals were maintained under specific pathogen-free conditions. All animal experiments were conducted in accordance with local and institutional guidelines.
Abs and flow cytometry mAb specific for CD4 (RM4-5, GK1.5), CD8 (53-6.7), CD25 (PC61), CD44 (IM7), Gr-1 (RB6-8C5), TCRb (H57-597), erythroid cell marker (Ter-119), CD19 (1D3), CD11b (M1/70), CD11c (N418), pan-NK (DX5), CD45.1 (A20), CD45.2 (104), B220 (RA3-6B2), CD117 (ACK2), Sca-1 (E13-161.7), CD135 (A2F10), Stat5 (pY694), Bcl-2 (3F11), or CD127 (A7R34) were used purified or as biotin, BV421, Pacific Blue, eFluor450, FITC, Alexa 488, Alexa 647, PE, PerCP-Cy5.5 (PerCP-Cy5.5), PE-Cy7, allophycocyanin, allophycocyanin-Cy7, or allophycocyanin-eFluor780 conjugates. Abs were purified from hybridoma supernatants or were purchased from eBioscience, BD Biosciences, or BioLegend. PE-Cy7-conjugated streptavidin (BD Biosciences) was used to reveal staining with biotinylated mAb. Lineage-negative BM cells were analyzed using anti-lineage-PE-Cy7, anti-CD117-allophycocyanin, anti-Sca-1-allophycocyanin-Cy7, anti-CD135-PE, and anti-CD127-BV421. DN thymocytes were analyzed using anti-lineage-PE-Cy7, anti-CD25-PerCP-Cy5.5, anti-CD44-PE, anti-CD117-allophycocyanin, anti-CD8-Alexa 488, and anti-CD4-Alexa 488. Data were acquired on a BD LSRII flow cytometer and analyzed with FlowJo software (Tree Star). Lin 2 cells were isolated from total BM by staining cell suspensions with a lineage-specific Ab mixture (anti-CD4, anti-CD8, anti-CD19, anti-CD11b and anti-Gr-1, Ter-119, and DX5), followed by incubation with anti-rat-IgG-conjugated magnetic beads (Dynal, Invitrogen) and magnetic bead depletion of mature lineages. DN thymocytes were isolated from total thymocytes by staining cell suspensions with anti-CD4 (RL1.72) and anti-CD8 (M31), followed by lysis with Low Tox-M Rabbit Complement (Cedarlane Laboratories) and subsequent density gradient centrifugation with Lympholyte-M (Cedarlane Laboratories). Cells were then sorted on a FACS Aria II cell sorter (BD Biosciences). 
Competitive BM chimeras
OP9 cocultures
OP9 coculture assays were essentially performed as described previously (36) . Precursors were plated at an initial density of 10 4 -4 3 10 4 cells onto subconfluent OP9-GFP or OP9-DL1 monolayers at 5 3 10 4 cells/well in a 24-well plate. All cocultures were performed in the presence of 1 ng/ml IL-7 and 5 ng/ml Flt3 ligand for OP9-DL1 T cell differentiation assays and 5 ng/ml IL-7 and 5 ng/ml Flt3 ligand for OP9 cocultures. At day 4 of differentiation, the culture medium was exchanged. Contaminating OP9 cells were eliminated by filtering the harvested cocultured cells through a 70-mm cell strainer prior to flow cytometric analysis. For cultures of ,10
2 precursors, cells were plated directly onto 96-well plates containing 10 4 gamma-irradiated OP9-GFP or OP9-DL1 cells (15 Gy) using a FACS Aria II cell sorter. For CFSE labeling, cells were incubated in the presence of 2 mM CFSE in PBS for 2 min at room temperature and subsequently washed in excess ice cold PBS.
Cell death assays
All experiments were performed in MEM a Medium (Life Technologies) supplemented with 10% (v/v) heat-inactivated FCS, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 55 mM 2-ME, and 50 mg/ml gentamicin. fl/fl and miR-17∼92 D/D mice were cultured in U-shaped 96-well plates with IL-7 concentrations ranging between 0 and 10 ng/ml for 24 h. Viability was determined by propidium iodide staining, which was added to a final concentration of 1 mg/ml prior to flow cytometric acquisition.
Methylcellulose cultures
FACS-sorted CLPs were cultured in Methocult M3630 (StemCell Technologies, Vancouver, BC, Canada) containing IL-7, according to the manufacturer's instructions. Plates were inspected and numbers of colonies were determined 11 d after the start of cultures.
IL-7 stimulation and intracellular FACS staining
For pStat5 staining, sorted precursors were incubated in serum-free medium (StemSpan SFEM; StemCell Technologies) at 37˚C for 1 h prior to stimulation with a final concentration of 10 ng/ml recombinant murine IL-7 (PeproTech) for 0, 4, or 10 min. Staining of intracellular pStat5 was adopted from Wan et al. (37) . At the given time points, cells were immediately treated with paraformaldehyde at a final concentration of 2% (v/v) and fixed for 10 min at 37˚C. Fixed cells were permeabilized by incubation for 12 h at 220˚C in 90% methanol (v/v). Cells were then stained with anti-Stat5-Alexa 647 (pY694) for 40 min at room temperature. To be able to pool multiple experiments for statistical analysis, data were normalized based on the maximum degree of stimulation of controls after 10 min IL-7 treatment within an individual experiment, which was set to 100%. For Bcl-2 staining, sorted DN3 thymocytes were incubated in presence or absence of IL-7 (10 ng/ml) for 18 h in MEM a Medium (Life Technologies) supplemented with 10% (v/v) heat-inactivated FCS, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 55mM 2-ME, and 50 mg/ml gentamicin. Cells were stained for surface Ags before fixation at room temperature with IC fixation buffer for 30 min (eBioscience). Subsequently, the cells were stained with anti-Bcl-2-PE or anti-Bcl-2-A488 (3F11; BD Pharmingen) in permeabilization buffer (eBioscience) for 30 min at room temperature.
Statistical analysis
All analysis was performed using GraphPad Prism software. Data are represented as mean 6 SEM. Analysis of significance between two groups of mice was performed using unpaired Wilcoxon-Mann-Whitney tests. Analysis of limiting dilution cultures was performed using ELDA (38) .
Results
miR-17∼92-deficient thymocytes do not efficiently contribute to T cell development in competitive BM chimeras
To assess the function of miR-17∼92 in T cell development we crossed miR-17∼92 fl/fl mice (22) with vav-iCre transgenic mice (35) to generate mice lacking miR-17∼92 in all hematopoietic cells (termed miR-17∼92 D/D in this paper). We used these mice to generate competitive BM chimeras, which represent a rigorous in vivo system to assess potential defects in hematopoiesis in vivo. (Fig. 1A, 1B) . In contrast, thymocytes derived from miR-17∼92 D/D mice were barely detectable in competitive chimeras, contributing to ,0.1% of all thymocytes (Fig. 1A) . The majority of miR-17∼92 D/D donor-derived cells displayed an immature CD4 -
CD8
-DN phenotype (Fig. 1A ). Detailed analysis of BM-derived progenitors and thymocyte subsets showed that of all HSCs ∼40%, whereas of all MPPs and CLPs only 14 and 12% CLPs were of miR-17∼92 D/D origin, respectively. In contrast, in control chimeras, cells of 17∼92 fl/fl origin contributed with 83, 80, and 78% to HSCs, MPPs, and CLPs, respectively (Fig. 1B) . These data suggest that, under competitive conditions, hematopoiesis critically depends on miR-17∼92. Within the thymus, the relative contribution of miR-17∼92 D/D donor-derived cells to T cell development declined progressively. Only 3% of early T lineage progenitors (ETPs) were of miR-17∼92 D/D origin, dropping to 1 and 0.6% at the DN2 and DN3 stages, respectively. More mature DP and single-positive (SP) thymocytes of miR-17∼92 D/D origin were barely detectable in competitive chimeras (Fig. 1B) . Of note, we detected a somewhat higher frequency of splenic T cells of miR-17∼92 D/D origin when compared with their thymic SP counterparts, suggesting that loss of miR-17∼92 might be somewhat beneficial for peripheral T cells. Control chimeras showed that miR-17∼92 fl/fl cells contributed to T cell development to a similar degree as their wild-type competitors. Consistent with previous publications competitive chimeras also revealed a defect in B cell development (Fig. 1B) (22) . In line with the competitive disadvantage at the MPP stage, we detected a reduced contribution of miR-17∼92 D/D BM to myelopoiesis, represented by DC development and granulopoiesis, albeit to much lesser extent when compared with T cell development.
In conclusion, competitive BM chimeras revealed that miR-17∼92 is critical for development of multiple hematopoietic lineages with a particularly strong role in early T cell development.
Deletion of miR-17∼92 results in reduced thymic cellularity and stage-specific defects in T cell development at steady state Next, we assessed whether deletion of miR-17∼92 resulted in aberrant T cell development at steady state. Total thymus cellularity was reduced 1.8-fold in miR-17∼92 D/D mice, resulting to a large extent from reduced numbers of DP thymocytes when compared with 17∼92 fl/fl mice ( Fig. 2A-C) . Analysis of vav-iCre mice, miR-17∼92 +/fl , and miR-17∼92 +/D controls indicated that this defect was due to deletion of miR-17∼92 and not due to an effect mediated by the iCre transgene (Supplemental Fig. 1 ). Frequencies of DN and CD4 SP thymocytes were elevated resulting in virtually normal and slightly reduced cellularity, respectively, when compared with controls (Fig. 2B, 2C) .
Given the profound decline in early intrathymic competition when compared with BM-derived progenitors in chimeric mice, we performed a detailed analysis of the early stages of intrathymic development. Frequencies and absolute numbers of ETPs were reduced 14-fold in thymi of miR-17∼92 D/D mice when compared with controls (Fig. 2D, 2E) . A similar reduction of almost 10-fold in numbers was detected in the DN2 compartment. In contrast, numbers of DN3 and DN4 cells were essentially normal in miR-17∼92 D/D mice when compared with controls, suggesting that compensatory mechanisms are in place at steady state that support the generation of full DN3 and DN4 compartments (Fig. 2D, 2E ). Alternatively, DN3 and DN4 cells may accumulate due to the observed DN-to-DP block.
Taken together, our experiments revealed that miR-17∼92
mice displayed a profound defect in early T cell development as well as a partial block at the DN-to-DP transition. Thus, these data suggest that miR-17∼92 is required to maintain normal T cell development at steady state.
Reduced numbers and function of BM-derived T lineage progenitors in miR-17∼92-deficient mice
Reduced numbers of ETPs in miR-17∼92 D/D mice prompted us to test the hypothesis that this defect might result from a failure of prethymic progenitors to efficiently generate T cells. HSC numbers were only slightly affected by deletion of miR-17∼92 (Fig. 3A, 3C ). In contrast, frequencies of MPPs and CLPs within lin 2 BM, based on surface expression of CD135, CD117, and Sca-1 were reduced 3-and 2-fold, respectively, when compared with controls ( Fig. 3A-C) .
To test whether miR-17∼92-deficient CLPs displayed an altered potential to generate lymphocytes, we used limiting dilution cultures using the OP9 and OP9-DL1 systems to assess B and T lineage differentiation, respectively. CLPs from miR-17∼92 mice and control mice displayed similar T lineage potential on OP9-DL1 cultures with progenitor frequencies of 1:6 and 1:5, respectively (Fig. 3D) . In contrast, B lineage potential of miR-17∼92-deficient CLPs was 7-fold lower when compared with controls with a progenitor frequency of 1:43 when compared with 1:6 for controls. However, quantification of colony size in individual wells revealed differences between miR-17∼92-sufficient and miR-17∼92-deficient CLPs under both T lineage and B (Fig. 3E) .
In conclusion, deletion of miR-17∼92 results in failure of growth of both T and B lineage progeny. However, restriction of B, but not T, lineage potential, of CLPs suggests that miR-17∼92 affects B lymphopoiesis via an additional layer of regulation.
miR-17∼92-deficient DN3 and DN4 thymocytes fail to efficiently differentiate into DP thymocytes Fig. 2A) . Consistently, more DN3 and DN4 cells of miR-17∼92 D/D mice expressed intracellular TCRb, suggesting that miR-17∼92 does not perturb Tcrb rearrangement (Supplemental Fig. 2B ). We also noted an ∼2-fold reduction in frequencies of gdT cells within DN thymocytes, which corresponded to similar frequencies of gdT cells relative to total thymocyte numbers (Supplemental Fig. 3 ).
To directly assess the consequences of deletion of miR-17∼92 in DN3 and DN4 thymocytes, we used OP9-DL1 cocultures. Sorted DN3a, DN3b, and DN4a cells from miR-17∼92 D/D mice and controls were cultured for 8 d and analyzed at 2-d intervals. Development and accumulation of DP thymocytes was severely impaired in cultures with DN3a, DN3b, and DN4a cells from miR-17∼92 D/D mice when compared with controls (Fig. 4A, 4B ). Interestingly, DN3a cells showed a constant increase in DP formation, whereas DP frequencies in DN3b-derived cultures reached a plateau after 4 d and declined steeply after day 4 in DN4a-derived cultures. These differences suggest that the miR-17∼92-dependent step at the DN-to-DP transition occurs probably late at the DN4 stage and/or once cells have entered the DP stage. In addition, irrespective of the developmental stage of the starting population, cultures from miR-17∼92 D/D mice expanded less when compared with their miR-17∼92 fl/fl counterparts (Fig. 4C) . Most notably, cultures of miR-17∼92 D/D DN4a cells did not expand at all but rather resulted in a 10-fold loss of cells compared with input cell numbers (Fig. 4C) , further indicating that miR-17∼92 most prominently acts late at and/or after the DN-to-DP transition. To test whether the impaired expansion of miR-17∼92 D/D thymocytes resulted from reduced survival or proliferation, OP9-DL1 differentiation assays were performed employing CFSE-labeled DN3a, DN3b, and DN4a thymocytes. miR-17∼92 D/D cells were able to proliferate in all cultures, albeit to a reduced extent when compared with miR-17∼92 fl/fl cells (Fig. 4D, Supplemental Fig. 4A ). Interestingly, analysis of CFSE dilution in miR-17∼92 D/D DN4a cells revealed an increase in the proportion of undivided cells, indicating a preferential loss of divided cells during culture (Fig. 4D) . Comparative analysis of divided and undivided populations showed that only divided cells displayed a certain degree of differentiation, whereas all undivided cells had remained at a DN stage (Supplemental Fig. 4B ). To directly test whether lack of miR-17∼92 resulted in limited cell survival, we first assessed levels of the prosurvival protein Bcl-2 in freshly isolated DN4 thymocytes. To be able to most accurately determine differential protein expression by flow cytometry, control and miR-17∼92 D/D samples were spiked with equal amounts of congenic wild-type cells (CD45.1). miR-17∼92 fl/fl cells displayed virtually identical levels of Bcl-2 as the spike-in controls, whereas levels of Bcl-2 were reduced by 2-fold in miR-17∼92 D/D cells (Fig.  4E) . Consistently, miR-17∼92 D/D DN4 and DP cells displayed elevated levels of apoptosis when cultured for 24 and 48 h in serumfree medium (Fig. 4F) . Thus, we can conclude that contraction of miR-17∼92 D/D DN4a thymocyte cultures despite noticeable proliferation is due to a deficiency in survival. Impaired survival of post-b-selection thymocytes may explain the observed block at the DN-to-DP transition.
Analysis of differentiation in OP9-DL1 cultures revealed an emergence of a prominent CD4SP population (Fig. 4B) . As OP9-DL1 cells do not express MHC class II, generation of these cells was unlikely to be due to accelerated differentiation into mature CD4SP cells. Consistently, in thymi of miR-17∼92 D/D mice, we detected a substantial number of immature TCR low/-CD24 + CD4SP cells, whereas such cells were present at low numbers in miR-17∼92 fl/fl mice (Supplemental Fig. 4C ). In vitro as well as in vivo analysis of Lck-Cre 3 miR-17∼92 fl/fl mice, in which Cremediated deletion begins at the DN3 stage, revealed that the emergence of TCR low/-CD24 + CD4SP cells was a late consequence of deletion of miR-17∼92 (Supplemental Fig. 4D, 4E ). To test whether these cells might be wannabe DP thymocytes but fail to upregulate CD8, we assessed Cd8a mRNA expression in DN4 cells from miR-17∼92 D/D mice. Indeed, mRNA levels of Cd8a were 3-fold lower in these cells when compared with wild-type controls (Supplemental Fig. 4F ). Generation of an aberrant CD4SP population explained why at steady-state numbers of CD4SP thymocytes were not substantially reduced when analyzed solely based on CD4 and CD8 expression.
In summary, these data suggest that miR-17∼92 controls cell survival after thymocytes have passed b-selection. In consequence, lack of miR-17∼92 results in a developmental defect at the DN-to-DP transition affecting both the DN4 and DP stages. (Fig. 5A) . Because IL-7Ra can be considered a defining surface marker for CLPs, these data permit two nonmutually exclusive interpretations: either fewer CLPs, defined by surface expression of IL7Ra, are generated from MPPs in miR-17∼92 D/D mice or CLPs, defined as CD135 + CD117 int Sca-1 + cells, are generated at somewhat reduced numbers but fail to upregulate IL-7Ra. To distinguish between these scenarios, we assessed expression of IL-7Ra at the transition from MPPs to CLPs. Assuming that this transition involves a gradual upregulation of CD135 followed by downregulation of CD117, we subdivided lin -Sca-1 + cells into multiple virtual subpopulations based on expression of CD135 and CD117 (Fig. 5B) . Analysis of IL-7Ra expression on these virtual populations showed that control cells with lower expression of CD117 than MPPs displayed high and essentially uniform expression levels of IL-7Ra, which increased only slightly with loss of CD117. In contrast, miR-17∼92 D/D cells displayed a more gradual increase in IL-7Ra surface expression, and even cells with lowest CD117 expression had not fully upregulated IL-7Ra. These data suggest that bona fide CLPs were generated in the absence of The Journal of ImmunologymiR-17∼92 but failed to upregulate IL-7Ra to the same extent as their wild-type counterparts.
Consistently, in colony-forming assays in semisolid medium containing IL-7 alone CLPs from miR-17∼92 D/D mice generated 77-fold fewer colonies when compared with control (Fig. 5C) . Furthermore, the size of the few colonies derived from miR-17∼92
D/D
CLPs was substantially smaller than that recovered from controls (Fig. 5C ). These data suggest that miR-17∼92 controls signaling through IL-7Ra in CLPs via modulating its surface expression.
miR-17∼92 controls responsiveness to IL-7 signals in intrathymic T lineage progenitors
Next, we addressed whether impaired IL-7 signaling might contribute to reduced thymocyte survival at the DN-to-DP transition in miR-17∼92 D/D mice. Surface expression of IL-7Ra was reduced on miR-17∼92 D/D DN3 and DN4 cells when compared with controls (Fig. 6A) . To test whether reduced surface expression of IL-7Ra directly affected IL-7 signaling, sorted DN3 and DN4 cells were treated with IL-7 and phosphorylation of Stat5 was assessed by flow cytometry after 4 and 10 min. Both populations from 17∼92 D/D mice displayed reduced amounts of phospho-Stat5 after stimulation when compared with controls (Fig. 6B) . Consistent with our in vitro differentiation data this defect was more pronounced in DN4 cells than in DN3 thymocytes. Next, we tested whether impaired viability of thymocytes from miR-17∼92 D/D mice might be attributed to impaired responsiveness to IL-7 signals. miR-17∼92 D/D DN3 thymocytes failed to upregulate Bcl-2 protein after 18 h of culture in the presence of IL-7 (Fig. 6C) . Consistently, whereas wild-type control thymocytes exhibited a dose-dependent improvement in viability in the presence of IL-7 after 18 h of culture, neither DN3 nor DN4 cells from 17∼92 D/D mice responded with increased viability under these conditions (Fig. 6D) . We conclude that impaired IL-7R signaling predominantly at the DN4 stage was likely to result in defective T cell development of post-b-selection thymocytes in 17∼92 D/D mice. In summary, our data indicate that miR-17∼92 controls responsiveness to IL-7 signaling in both prethymic and intrathymic T cell progenitors.
Discussion
In this paper, we have provided evidence that miR-17∼92 is critical for T cell development at prethymic and intrathymic stages. In contrast to its role in B cell development and lymphoid leukemogenesis, the contribution of miR-17∼92 to T cell development has remained elusive (16, 17, 22) . It had been suggested that, based on the presence of T cells in spleens in chimeras reconstituted with miR-17∼92-deficient fetal liver cells, miR-17∼92 played no role in T cell development (22) . However, in the absence of competition partially defective T cell development might suffice to fill up peripheral T cell niches. This explanation is consistent with our observation that the effects of deletion of miR-17∼92 in hematopoietic cells are more apparent under competitive conditions when compared with the steady state. Furthermore, the consequences of deletion of miR-17∼92 in competitive chimeras were somewhat alleviated in peripheral T cells when compared with their SP thymocyte counterparts.
Mice lacking miR-17∼92 in all hematopoietic cells displayed impaired numbers and function of BM-derived lymphoid progenitors as well as thymocytes. Functional analysis suggested that prethymic and intrathymic defects in the absence of miR-17∼92 are at least in part due to limited responsiveness to IL-7 signals. In addition, miR-17∼92 D/D mice showed reduced numbers of MPPs, which also resulted in reduced numbers of myeloid cells in competitive BM chimeras. However, the lack of an additional decrease in frequencies of myeloid cells when compared with MPPs suggested that myelopoiesis beyond multipotent progenitor stages is unaffected by deletion of miR-17∼92.
IL-7R signaling differentially affects various stages of lymphocyte development. Thus, although Il7-deficiency results in overall reduced survival of developing lymphocytes, a direct block in differentiation at the CLP stage is only observed for the B lineage in mice (12) (13) (14) . Furthermore, whereas IL-7 signaling is continually required for promoting survival signals during early intrathymic T cell development, developmental-stage dependent differences have also been described. For instance, development of gdT cells is completely abrogated in Il7ra 2/2 mice, because rearrangement of the Tcrg locus critically depends on IL-7R signaling (15, 40) . Pre-TCR signaling induces upregulation of IL-7Ra. Consequently, IL-7 signaling promotes survival of DN4 thymocytes and is, therefore, required for efficient generation of DP cells (41) . Our data indicate that miR-17∼92 promotes intrathymic T cell development predominantly at this specific stage. Accordingly, gdT cell development was only mildly affected in miR-17∼92 D/D mice. This observation is also consistent with our observation that T cell development from the DN2 stage to the b-selection checkpoint recovers in these mice at steady state, although survival at these stages depends on IL-7 as well (42) .
Expression of IL-7Ra was reduced in the absence of miR-17∼92 despite the fact that miRNAs are generally considered to be negative regulators of gene expression. Thus, one might hypothesize that miR-17∼92 controls one or more negative regulators of Il7ra expression. Regulation of Il7ra in T lineage cells is poorly understood. Few transcriptional repressors of Il7ra, such as Satb1 and Gfi1B, have been identified and it has been shown that downstream effectors of the suppressor of cytokine signaling family negatively regulate surface expression of IL-7Ra (43) (44) (45) . However, none of these candidate genes could be identified as functional target of miR-17∼92 (M. Regelin and A. Krueger, unpublished observations).
Experiments employing competitive BM chimeras showed more severe defects in the absence of miR-17∼92 when compared with the consequences of deletion of miR-17∼92 at steady state. These findings are consistent with a scenario, in which progenitors compete for access to a limited number of intrathymic niches. In line with this concept, thymi of Il7ra-deficient mice are particularly receptive for progenitor entry and in the complete absence of competent extrathymic progenitors thymopoiesis originating from intrathymic progenitors is sustained over extended periods of time (46) (47) (48) . Furthermore, naturally occurring overexpression of IL7Ra on T cell progenitors of AKR/J mice confers a competitive advantage ultimately resulting in development of thymoma (49) . Conversely, progenitors with a reduced capacity for thymus entry, such as those from CCR7 and CCR9 double-deficient mice are out-competed by wild-type progenitors upon transplantation, whereas they allow T cell development at steady state (50, 51) . Similarly, Tcf-1-deficient progenitors do not differentiate beyond the DN2 stage in mixed BM chimeras, but are able to give rise to mature thymocytes, albeit to a limited extent, at steady state (52, 53) . Interestingly, in all of these cases recovery of thymocyte subsets predominantly occurred toward DN3 cells, suggesting that the thymus contains a defined number of niches for these cells to be filled irrespective of numbers of precursors present. However, the molecular or morphological requirements for regulation of niche size remain thus far elusive.
Pten and Bim have been suggested to constitute major downstream targets of miR-17∼92 in lymphocytes, and B cell development in particular. Thus, upregulation of Bim has been proposed to result in impaired B cell development in the absence of miR-17∼92 (22) . However, we did not observe any alteration in Bim or Pten mRNA levels in developing T cells (R. Vakilzadeh and A. Krueger, unpublished observations). IL-7R signaling promotes cell survival by inhibiting Bim function in developing T and B cells as well as peripheral T cells (54) (55) (56) . Thus, one could speculate that in B cells as well miR-17∼92-dependent modulation of IL-7R signaling might provide an additive effect for cell survival and, in developing T cells, might replace direct regulation of Bim. Similarly, IL-7 stimulation triggers the PI3K/Akt pathway, which is negatively regulated by Pten. Therefore, this pathway may be controlled by miR-17∼92 at at least two distinct levels, silencing of the negative regulator Pten and enhancing IL-7R signaling. Again, it remains possible that these two modes of regulation are not operational simultaneously in all cell populations. This scenario is consistent with the idea that miRNAs exert their function by cotargeting multiple genes within a given pathway to a relatively small degree rather than serving as on-offswitches for the expression of individual genes (57) .
In summary, we have identified a critical role for miR-17∼92 in T cell development. miR-17∼92 controlled responsiveness of various prethymic and intrathymic T cell progenitors to IL-7. Thus, our study integrates cell-intrinsic miRNA-mediated gene regulation and cell-extrinsic developmental cues, such as cytokine signaling. Identification of miR-17∼92 function beyond B cell development underscores the role of this miRNA cluster as a key player during lymphopoiesis.
